Upcoming webinar: SMA Academy – Hot Topics in Basic SMA Research
NMD4C and Biogen are pleased to invite you to our SMA Academy session on Hot Topics in Basic SMA Research, chaired by NMD4C steering committee member Dr. Rashmi Kothary.
Tuesday, Sept. 22 at 5:00pm ET
The SMA Academy has been developed in partnership with Biogen. The content and design of the presentations are created entirely by the individual speakers, and any potential conflicts of interest will be disclosed. The opinions presented are those of the presenters and are not necessarily those of Biogen Canada Inc.
If you have any questions, please email
Register HERE
Objectives:
- Discuss the latest scientific research on the systemic nature of SMA
- Discuss the role of biomarkers in characterization of SMA severity and response to treatment
- Discuss the metabolic implications of SMA
Topics and speakers:
Lost in translation: The systemic features of SMA
Dr. Marc-Olivier Deguise
Using pre-clinical models to better understand metabolic demands and nutritional support in SMA
Dr. Melissa Bowerman
Biomarkers in SMA
Dr. Robin Parks
Panel discussion led by Dr. Rashmi Kothary
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.